van Roozendaal, L. M. http://orcid.org/0000-0003-4831-1679
Vane, M. L. G. http://orcid.org/0000-0003-4514-5329
Colier, E. http://orcid.org/0000-0002-1919-447X
Strobbe, L. J. A. http://orcid.org/0000-0002-3840-3003
de Boer, M. http://orcid.org/0000-0002-0835-8651
Sonke, G. http://orcid.org/0000-0001-8088-9628
Van Maaren, M. C. http://orcid.org/0000-0002-5708-2559
Smidt, M. L. http://orcid.org/0000-0002-8328-1869
Article History
Received: 28 May 2023
Accepted: 16 September 2023
First Online: 5 October 2023
Declarations
:
: The following authors hereby disclose the potential conflicts of interest. G. Sonke received research grants paid to the institution by Agendia, Biovica, AstraZeneca, Merck, Novartis, Roche, and Seagon. M.L. Smidt received research grant paid to the institution by Servier Pharma and Nutricia for microbiome research. Other authors declare that they have no potential financial or non-financial interest to disclose.
: This is an observational study with irreducible data from the nationwide population-based Netherlands Cancer Registry and was thereby granted exemption for ethics approval.